https://www.webmd.com/breast-cancer/breast-cancer-brca-gene-test#...

https://www.webmd.com/breast-cancer/breast-cancer-brca-gene-test#1

GTG was performing BRACA under the licence from Myriad in Australia.

Now no licence necessary. Brevagen is just complementary.

The new Board was proposing to Roll Out Brevagen in Australia I reason they would do together with BRACA which is less volume but much higher price.

In US Myriad has Brand Name but in Australia GTG can roll out with no opposition then move on to the World.

Myriad started as a small company and GENE can do it too under a right management and with advantage of Blockchain.

Just my opinion.